» Articles » PMID: 23269317

The Neurovascular Unit As a Selective Barrier to Polymorphonuclear Granulocyte (PMN) Infiltration into the Brain After Ischemic Injury

Abstract

The migration of polymorphonuclear granulocytes (PMN) into the brain parenchyma and release of their abundant proteases are considered the main causes of neuronal cell death and reperfusion injury following ischemia. Yet, therapies targeting PMN egress have been largely ineffective. To address this discrepancy we investigated the temporo-spatial localization of PMNs early after transient ischemia in a murine transient middle cerebral artery occlusion (tMCAO) model and human stroke specimens. Using specific markers that distinguish PMN (Ly6G) from monocytes/macrophages (Ly6C) and that define the cellular and basement membrane boundaries of the neurovascular unit (NVU), histology and confocal microscopy revealed that virtually no PMNs entered the infarcted CNS parenchyma. Regardless of tMCAO duration, PMNs were mainly restricted to luminal surfaces or perivascular spaces of cerebral vessels. Vascular PMN accumulation showed no spatial correlation with increased vessel permeability, enhanced expression of endothelial cell adhesion molecules, platelet aggregation or release of neutrophil extracellular traps. Live cell imaging studies confirmed that oxygen and glucose deprivation followed by reoxygenation fail to induce PMN migration across a brain endothelial monolayer under flow conditions in vitro. The absence of PMN infiltration in infarcted brain tissues was corroborated in 25 human stroke specimens collected at early time points after infarction. Our observations identify the NVU rather than the brain parenchyma as the site of PMN action after CNS ischemia and suggest reappraisal of targets for therapies to reduce reperfusion injury after stroke.

Citing Articles

Neutrophil-related immune-inflammatory biomarkers influence the early progression of medial medullary infarction.

Li L, Cai H Front Neurol. 2025; 16:1528560.

PMID: 40078176 PMC: 11896845. DOI: 10.3389/fneur.2025.1528560.


Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation.

Barba L, Vollmuth C, Halbgebauer S, Ungethum K, Hametner C, Essig F Eur J Neurol. 2024; 32(1):e16581.

PMID: 39714176 PMC: 11664725. DOI: 10.1111/ene.16581.


Uncovering the dual roles of peripheral immune cells and their connections to brain cells in stroke and post-stroke stages through single-cell sequencing.

Xu Z, Yang F, Zheng L Front Neurosci. 2024; 18:1443438.

PMID: 39633897 PMC: 11614781. DOI: 10.3389/fnins.2024.1443438.


The neutrophil extracellular traps in neurological diseases: an update.

Yu X, Chen Z, Bao W, Jiang Y, Ruan F, Wu D Clin Exp Immunol. 2024; 218(3):264-274.

PMID: 38975702 PMC: 11557138. DOI: 10.1093/cei/uxae057.


Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator.

Huang Y, Han Z, Shen T, Zheng Y, Yang Z, Fan J CNS Neurosci Ther. 2024; 30(7):e14825.

PMID: 38954749 PMC: 11218914. DOI: 10.1111/cns.14825.


References
1.
Maeda K, Hata R, Hossmann K . Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice. Neuroreport. 1998; 9(7):1317-9. DOI: 10.1097/00001756-199805110-00012. View

2.
Krams M, Lees K, Hacke W, Grieve A, Orgogozo J, Ford G . Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke. 2003; 34(11):2543-8. DOI: 10.1161/01.STR.0000092527.33910.89. View

3.
Katchanov J, Waeber C, Gertz K, Gietz A, Winter B, Bruck W . Selective neuronal vulnerability following mild focal brain ischemia in the mouse. Brain Pathol. 2003; 13(4):452-64. PMC: 8095859. DOI: 10.1111/j.1750-3639.2003.tb00476.x. View

4.
Zhang E, Inman C, Weller R . Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J Anat. 1990; 170:111-23. PMC: 1257067. View

5.
Engelhardt B, Conley F, Kilshaw P, Butcher E . Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int Immunol. 1995; 7(3):481-91. DOI: 10.1093/intimm/7.3.481. View